Treatment Effect of Edaravone in Patients With Amyotrophic Lateral Sclerosis (ALS) in a Representative Iranian Population
Phase of Trial: Phase I/II
Latest Information Update: 22 Jan 2018
At a glance
- Drugs Edaravone (Primary) ; Riluzole
- Indications Amyotrophic lateral sclerosis
- Focus Therapeutic Use
- 15 Jan 2018 Status changed from not yet recruiting to recruiting.
- 09 Sep 2017 Planned End Date changed from 6 Mar 2019 to 16 Mar 2019.
- 09 Sep 2017 Planned primary completion date changed from 6 Mar 2019 to 16 Mar 2019.